BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 3102892)

  • 1. The role of prostaglandin synthesis inhibition in the renal syndromes associated with non-narcotic analgesics.
    Patrono C
    Med Toxicol; 1986; 1 Suppl 1():23-33. PubMed ID: 3102892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arachidonic acid derivatives and renal function in liver cirrhosis.
    Laffi G; La Villa G; Pinzani M; Marra F; Gentilini P
    Semin Nephrol; 1997 Nov; 17(6):530-48. PubMed ID: 9353864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal cyclo-oxygenase and lipoxygenase products in health and disease.
    Dunn MJ; Scharschmidt LA; Lianos EA; Konieczkowski M
    Clin Physiol Biochem; 1984; 2(2-3):91-100. PubMed ID: 6435931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Indications and contraindications for the use of nonsteroidal antiinflammatory drugs in urology.
    Weisman SM; Felsen D; Vaughan ED
    Semin Urol; 1985 Nov; 3(4):301-10. PubMed ID: 3939661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Renal functional effects of non-steroidal anti-inflammatory agents and prostaglandins].
    Ryckelynck JP; Hurault de Ligny B
    Nephrologie; 1988; 9(3):125-8. PubMed ID: 3057393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal toxicity of non-narcotic analgesics. At-risk patients and prescribing applications.
    Kincaid-Smith P
    Med Toxicol; 1986; 1 Suppl 1():14-22. PubMed ID: 3546999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-inflammatory drugs and their effects on cartilage synthesis and renal function.
    Shield MJ
    Eur J Rheumatol Inflamm; 1993; 13(1):7-16. PubMed ID: 7821339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Do non-steroidal anti-inflammatory drugs and COX-2 selective inhibitors have different renal effects?
    Giovanni G; Giovanni P
    J Nephrol; 2002; 15(5):480-8. PubMed ID: 12455713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal functional responses to ischaemia-reperfusion injury in normotensive and hypertensive rats following non-selective and selective cyclo-oxygenase inhibition with nitric oxide donation.
    Knight S; Johns EJ
    Clin Exp Pharmacol Physiol; 2008 Jan; 35(1):11-6. PubMed ID: 18047621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of nonsteroidal anti-inflammatory drugs on renal function: experimental studies in animals.
    Zambraski EJ
    Semin Nephrol; 1995 May; 15(3):205-13. PubMed ID: 7631047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Review article: prevention of non-steroidal anti-inflammatory drug gastrointestinal complications--review and recommendations based on risk assessment.
    Chan FK; Graham DY
    Aliment Pharmacol Ther; 2004 May; 19(10):1051-61. PubMed ID: 15142194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostaglandins in the kidney: developments since Y2K.
    Nasrallah R; Clark J; Hébert RL
    Clin Sci (Lond); 2007 Oct; 113(7):297-311. PubMed ID: 17760567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of arachidonic acid metabolites in renal homeostasis. Non-steroidal anti-inflammatory drugs renal function and biochemical, histological and clinical effects and drug interactions.
    Dunn M
    Drugs; 1987; 33 Suppl 1():56-66. PubMed ID: 3109872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-steroidal anti-inflammatory drugs and the continuum of renal dysfunction.
    Epstein M
    J Hypertens Suppl; 2002 Sep; 20(6):S17-23. PubMed ID: 12683423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NSAIDs, prostaglandins and the neonatal kidney.
    Antonucci R; Fanos V
    J Matern Fetal Neonatal Med; 2009; 22 Suppl 3():23-6. PubMed ID: 19701861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostaglandin I2 and the kidney.
    Dunn MJ
    Arch Mal Coeur Vaiss; 1989 Nov; 82 Spec No 4():27-31. PubMed ID: 2514664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX-2 inhibitor.
    Riendeau D; Percival MD; Boyce S; Brideau C; Charleson S; Cromlish W; Ethier D; Evans J; Falgueyret JP; Ford-Hutchinson AW; Gordon R; Greig G; Gresser M; Guay J; Kargman S; Léger S; Mancini JA; O'Neill G; Ouellet M; Rodger IW; Thérien M; Wang Z; Webb JK; Wong E; Chan CC
    Br J Pharmacol; 1997 May; 121(1):105-17. PubMed ID: 9146894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stimulation and inhibition of renal PG biosynthesis: effects on renal blood flow and on plasma renin activity.
    Larsson C; Weber P; Anggård E
    Acta Biol Med Ger; 1976; 35(8-9):1195-200. PubMed ID: 1007775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Non-steroidal anti-inflammatory agents (NSAID's) with lesser side effects by selective inhibition of cyclo-oxygenase-2].
    Bijlsma JW; Van de Putte LB
    Ned Tijdschr Geneeskd; 1998 Aug; 142(31):1762-5. PubMed ID: 9856140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of NSAIDs in rheumatic disorders 2005: a global perspective.
    Kean WF; Buchanan WW
    Inflammopharmacology; 2005; 13(4):343-70. PubMed ID: 16354389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.